TransThera Sciences (Nanjing), Inc. (HKG:2617)
Hong Kong · Delayed Price · Currency is HKD 10.31
-0.07 (-0.67%)
Aug 21, 2026, 4:08 PM HKT
HKG:2617 Market Cap
HKG:2617 has a market cap or net worth of 4.21 billion as of August 21, 2026. Its market cap has decreased by -79.38% in one year.
Market Cap
4.21B
Enterprise Value
3.66B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
10.31
ChartMarket Cap Chart
Since June 23, 2025, HKG:2617's market cap has decreased from 9.33B to 4.21B, a decrease of -54.91%. That is a compound annual growth rate of -49.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 4.21B | -90.78% |
| Dec 31, 2025 | 45.60B | 388.94% |
| Jun 23, 2025 | 9.33B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shanghai Bao Pharmaceuticals | 5.25B |
| Ocumension Therapeutics | 4.33B |
| Hanx Biopharmaceuticals (Wuhan) | 4.24B |
| Jacobio Pharmaceuticals Group | 4.12B |
| Qyuns Therapeutics | 3.79B |
| Mirxes Holding Company | 3.66B |
| Medtide | 3.31B |
| Viva Biotech Holdings | 3.30B |